Merck 2010 Annual Report Download - page 120

The individual values are presented in the following table:

Fixed compensation Variable compensation Total compensation
EUR 2010 2009 2010 2009 2010 2009
Prof. Dr. Dr. h.c. Rolf Krebs 1
(Chairman since July 1, 2009,
previously ordinary member) 14,000 10,500 46,288 26,779 60,288 37,279
Heiner Wilhelm (Vice Chairman) 10,500 10,500 34,716 26,779 45,216 37,279
Crocifissa Attardo
(since Oct. 1, 2009) 7,000 1,750 23,144 4,463 30,144 6,213
Dr. Mechthild Auge
(since March 25, 2009) 7,000 5,408 23,144 13,793 30,144 19,201
Johannes Baillou 47,000 7,000 23,144 17,853 30,144 24,853
Frank Binder 47,000 7,000 23,144 17,853 30,144 24,853
Dr. Wolfgang Büchele 2
(since July 1, 2009) 7,000 3,500 23,144 8,926 30,144 12,426
Michael Fletterich 7,000 7,000 23,144 17,853 30,144 24,853
Edeltraud Glänzer 7,000 7,000 23,144 17,853 30,144 24,853
Michaela Freifrau von Glenck 57,000 7,000 23,144 17,853 30,144 24,853
Frieder Kaufmann 7,000 7,000 23,144 17,853 30,144 24,853
Dr. Hans-Jürgen Leuchs 2
(since July 1, 2009) 7,000 3,500 23,144 8,926 30,144 12,426
Albrecht Merck 37,000 7,000 23,144 17,853 30,144 24,853
Dr. Karl-Heinz Scheider
(since March 25, 2009) 7,000 5,408 23,144 13,793 30,144 19,201
Prof. Dr. Theo Siegert 17,000 7,000 23,144 17,853 30,144 24,853
Osman Ulusoy 7,000 7,000 23,144 17,853 30,144 24,853
Prof. Dr. Wilhelm Simson 6
(until June 30, 2009, Chairman) 0.0 7,000 0.0 17,853 0.0 24,853
Dr. Daniele Bruns
(until March 24, 2009) 0.0 1,591 0.0 4,060 0.0 5,651
Claudia Flauaus
(until Sept. 30, 2009) 0.0 5,250 0.0 13,389 0.0 18,639
Judith Delp
(until March 24, 2009) 0.0 1,591 0.0 4,060 0.0 5,651
Dr. Arend Oetker 6
(until June 30, 2009) 0.0 3,500 0.0 8,926 0.0 12,426
Total 122,500 122,498 405,020 312,424 527,520 434,922
1 As members of corporate bodies of E. Merck KG, these Supervisory Board members each received an additional payment of EUR 150,000
for performing this function in 2010 (2009: EUR 120,000).
2 As members of corporate bodies of E. Merck KG, these Supervisory Board members each received an additional payment of EUR 140,000
for performing this function in 2010 (2009: EUR 60,000).
3 As members of corporate bodies of E. Merck KG, these Supervisory Board members each received an additional payment of EUR 120,000
for performing this function in 2010 (2009: EUR 120,000 ).
4 As members of corporate bodies of E. Merck KG, these Supervisory Board members each received an additional payment of EUR 120,000
for performing this function in 2010 (2009: EUR 100,000).
5 As members of corporate bodies of E. Merck KG, these Supervisory Board members each received an additional payment of EUR 80,000 for
performing this function in 2010 (2009: EUR 80,000).
6 As members of corporate bodies of E. Merck KG, these Supervisory Board members, who retired from the Supervisory Board in 2009, and
were simultaneously members of bodies of E. Merck KG, each received an additional payment of EUR 60,000 for performing this function
in 2009.
Merck Annual Report 2010 116